| 000 | 01804 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250518094930.0 | ||
| 264 | 0 | _c20210702 | |
| 008 | 202107s 0 0 eng d | ||
| 022 | _a1557-3125 | ||
| 024 | 7 |
_a10.1158/1541-7786.MCR-19-1244 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aStern, Josh Lewis | |
| 245 | 0 | 0 |
_aMesenchymal and MAPK Expression Signatures Associate with Telomerase Promoter Mutations in Multiple Cancers. _h[electronic resource] |
| 260 |
_bMolecular cancer research : MCR _c07 2020 |
||
| 300 |
_a1050-1062 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 | _aChromatin Immunoprecipitation |
| 650 | 0 | 4 |
_aEpithelial-Mesenchymal Transition _xdrug effects |
| 650 | 0 | 4 |
_aExtracellular Signal-Regulated MAP Kinases _xdrug effects |
| 650 | 0 | 4 |
_aGene Expression Profiling _xmethods |
| 650 | 0 | 4 |
_aGene Expression Regulation, Neoplastic _xdrug effects |
| 650 | 0 | 4 |
_aGene Regulatory Networks _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aPromoter Regions, Genetic _xdrug effects |
| 650 | 0 | 4 | _aSequence Analysis, RNA |
| 650 | 0 | 4 |
_aSmall Molecule Libraries _xpharmacology |
| 650 | 0 | 4 |
_aTelomerase _xgenetics |
| 650 | 0 | 4 | _aTumor Microenvironment |
| 700 | 1 | _aHibshman, Grace | |
| 700 | 1 | _aHu, Kevin | |
| 700 | 1 | _aFerrara, Sarah E | |
| 700 | 1 | _aCostello, James C | |
| 700 | 1 | _aKim, William | |
| 700 | 1 | _aTamayo, Pablo | |
| 700 | 1 | _aCech, Thomas R | |
| 700 | 1 | _aHuang, Franklin W | |
| 773 | 0 |
_tMolecular cancer research : MCR _gvol. 18 _gno. 7 _gp. 1050-1062 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1158/1541-7786.MCR-19-1244 _zAvailable from publisher's website |
| 999 |
_c30844244 _d30844244 |
||